#adnagen

Circulating Tumor Cells Market Is Anticipated to Attain Around USD 11,552.3 Million By 2022:Key Participant Canopus Biosciences, Clearbridge BioMedics

Global circulating tumor cells market is anticipated to reach USD 11,552.3 million by 2022, according to a new report by Grand View Research, Inc. Rising developments in the field of biomedical engineering and biomedical imaging coupled with rise in patented research initiatives by the government is expected to drive this industry through the forecast period.

Introduction of novel technologies…